MIRA Pharmaceuticals, Inc.
MIRA
$0.9389
-$0.1311-12.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.85M | -11.24M | -12.78M | -12.36M | -11.98M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -732.30K | -292.90K | 0.00 | 0.00 |
| Total Other Non-Cash Items | 1.92M | 7.15M | 8.31M | 8.44M | 8.09M |
| Change in Net Operating Assets | 371.20K | 34.90K | 62.40K | -588.00K | -639.70K |
| Cash from Operations | -5.56M | -4.79M | -4.71M | -4.51M | -4.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 2.15M | 2.15M | 1.38M | 2.15M |
| Total Debt Repaid | 0.00 | -1.02M | -1.01M | -1.17M | -1.14M |
| Issuance of Common Stock | 3.61M | 3.13M | 9.05M | 9.05M | 9.05M |
| Repurchase of Common Stock | -- | -1.35M | -1.35M | -1.35M | -1.35M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 182.40K | 163.20K | -1.33M | 120.50K | 74.20K |
| Cash from Financing | 3.79M | 3.07M | 7.51M | 8.03M | 8.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.77M | -1.72M | 2.80M | 3.53M | 4.25M |